Stay updated on Pembrolizumab with Radiotherapy in CTCL Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Radiotherapy in CTCL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Radiotherapy in CTCL Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number changed from v3.7.2 to v3.8.0; the study record is still not displayed.
    Difference
    0.2%
    Check dated 2026-10-31T12:45:45.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T17:03:25.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer’s site revision marker changed from v3.7.1 to v3.7.2 on the access-denied page.
    Difference
    0.2%
    Check dated 2026-10-17T16:49:16.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision advances from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T17:16:28.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error, replacing the content with an access message and site chrome. This indicates blocked access rather than an update to trial data or page functionality.
    Difference
    19%
    Check dated 2026-09-19T20:29:49.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    NIH grant/contract information was added to the study identifiers. The site revision was updated to v3.6.6 and the previous revision v3.6.5 was removed.
    Difference
    0.1%
    Check dated 2026-08-29T22:12:37.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Radiotherapy in CTCL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radiotherapy in CTCL Clinical Trial page.